KENNEY CHRISTOPHER JOHN (Chief Medical Officer) sold 100.0% of their position (7.07K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $425.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/1/2026ACC: 0001193125-26-377309
Officer· Chief Medical Officer
Since Aug 2021
-7.07K
Net shares
Net seller
$425.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.07K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−6.37K
Price / share
$60.17
Trade value
$383.15K
% of position
90.1%
8/28/2026
7.07K→702.00
Common Shares
Direct
Shares
−700.00
Price / share
$60.98
Trade value
$42.68K
% of position
99.7%
8/28/2026
702.00→2.00
Total
Net shares
−7.07K
Net value
-$425.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/28/2026 | S · Sale | −6.37K | $60.17 | $383.15K | 90.1% | 7.07K | 702.00 |
| Common Shares Direct | 8/28/2026 | S · Sale | −700.00 | $60.98 | $42.68K | 99.7% | 702.00 | 2.00 |
| Total | −7.07K | -$425.83K | ||||||
Derivative Transactions0
No derivative transactions reported